Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELY-ABLE long-term extension of dabigatran treatment
2008-005248-17Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dabigatran in Atrial fibrillation (AFib) and stroke, sponsored by Boehringer Ingelheim. Primary endpoint: Major bleeding events. Started Sep 2008; status: completed.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)stroke
Beyond the preview
Go deeper on 2008-005248-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005248-17.